OP NanoPharma Co., Ltd.

OP NanoPharma (OPN) is a Taiwan-based pharmaceutical company specializing in sterile injectable CDMO/CMO services and licensing opportunities. Our US FDA-inspected and PIC/S GMP-compliant facility supports formulation and lyophilization development, technology transfer, aseptic fill-finish, clinical supply, and commercial manufacturing for solution and lyophilized vial products. OPN also offers capabilities for HPAPI, cytotoxic/non-cytotoxic products, and ADC drug product fill-finish. We welcome CDMO partnerships and licensing collaborations for our ready-to-partner injectable pipeline.